Taimei Medical Proposes H-Share Award Scheme Using Existing Shares, Calls Extraordinary Meeting for Approval

Bulletin Express05-18

Zhejiang Taimei Medical Technology Co., Ltd. (“Taimei Medical”, HKEX: 02576) announced that its Board resolved on 18 May 2026 to introduce an H-Share Award Scheme (Existing Shares).

The initiative aims to strengthen the company’s long-term incentive framework by aligning employee interests with those of shareholders and the company’s sustainable development goals. Awards will be satisfied solely with existing H shares; no new shares will be issued.

Regulatory status: • The plan is classified as a “share scheme involving existing shares” under Chapter 17 of the Hong Kong Listing Rules and falls within Rule 17.12. • Because it does not involve new share issuance, it is exempt from shareholder approval under the Listing Rules. • Nonetheless, Taimei Medical’s Articles of Association require shareholder endorsement via special resolutions, so the proposal will be tabled at an upcoming extraordinary general meeting (EGM).

Next steps: • A circular detailing the H-Share Award Scheme and the EGM notice will be dispatched in due course. • The company advises shareholders and potential investors to exercise caution when dealing in its securities until the EGM outcome is known.

Board composition (as of the announcement date): Executive Directors – Dr. Zhao Lu (Chairman), Ma Dong, Zhang Hongwei, Lu Yiming, Huang Yufei, Ni Xiaomei Independent Non-executive Directors – Dr. Jiang Xiao, Dr. Li Zhiguo, Fung Che Wai Anthony

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1169737411?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-18 22:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169737411","market":"hk","top_or_hot":-1,"title":"Taimei Medical Proposes H-Share Award Scheme Using Existing Shares, Calls Extraordinary Meeting for Approval","media":"Bulletin Express","content":"<p>Zhejiang Taimei Medical Technology Co., Ltd. (“Taimei Medical”, HKEX: 02576) announced that its Board resolved on 18 May 2026 to introduce an H-Share Award Scheme (Existing Shares).</p>\n<p>The initiative aims to strengthen the company’s long-term incentive framework by aligning employee interests with those of shareholders and the company’s sustainable development goals. Awards will be satisfied solely with existing H shares; no new shares will be issued.</p>\n<p>Regulatory status:\n•  The plan is classified as a “share scheme involving existing shares” under Chapter 17 of the Hong Kong Listing Rules and falls within Rule 17.12.  \n•  Because it does not involve new share issuance, it is exempt from shareholder approval under the Listing Rules.  \n•  Nonetheless, Taimei Medical’s Articles of Association require shareholder endorsement via special resolutions, so the proposal will be tabled at an upcoming extraordinary general meeting (EGM).</p>\n<p>Next steps:\n•  A circular detailing the H-Share Award Scheme and the EGM notice will be dispatched in due course.  \n•  The company advises shareholders and potential investors to exercise caution when dealing in its securities until the EGM outcome is known.</p>\n<p>Board composition (as of the announcement date):  \nExecutive Directors – Dr. Zhao Lu (Chairman), Ma Dong, Zhang Hongwei, Lu Yiming, Huang Yufei, Ni Xiaomei  \nIndependent Non-executive Directors – Dr. Jiang Xiao, Dr. Li Zhiguo, Fung Che Wai Anthony</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Taimei Medical Proposes H-Share Award Scheme Using Existing Shares, Calls Extraordinary Meeting for Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTaimei Medical Proposes H-Share Award Scheme Using Existing Shares, Calls Extraordinary Meeting for Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-18 22:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zhejiang Taimei Medical Technology Co., Ltd. (“Taimei Medical”, HKEX: 02576) announced that its Board resolved on 18 May 2026 to introduce an H-Share Award Scheme (Existing Shares).</p>\n<p>The initiative aims to strengthen the company’s long-term incentive framework by aligning employee interests with those of shareholders and the company’s sustainable development goals. Awards will be satisfied solely with existing H shares; no new shares will be issued.</p>\n<p>Regulatory status:\n•  The plan is classified as a “share scheme involving existing shares” under Chapter 17 of the Hong Kong Listing Rules and falls within Rule 17.12.  \n•  Because it does not involve new share issuance, it is exempt from shareholder approval under the Listing Rules.  \n•  Nonetheless, Taimei Medical’s Articles of Association require shareholder endorsement via special resolutions, so the proposal will be tabled at an upcoming extraordinary general meeting (EGM).</p>\n<p>Next steps:\n•  A circular detailing the H-Share Award Scheme and the EGM notice will be dispatched in due course.  \n•  The company advises shareholders and potential investors to exercise caution when dealing in its securities until the EGM outcome is known.</p>\n<p>Board composition (as of the announcement date):  \nExecutive Directors – Dr. Zhao Lu (Chairman), Ma Dong, Zhang Hongwei, Lu Yiming, Huang Yufei, Ni Xiaomei  \nIndependent Non-executive Directors – Dr. Jiang Xiao, Dr. Li Zhiguo, Fung Che Wai Anthony</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02576","symbol_name":"太美医疗科技","start_time":0,"source_url":"","article_id":"1169737411","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169737411","pubTimestamp":1779112977,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zhejiang Taimei Medical Technology Co., Ltd. (“Taimei Medical”, HKEX: 02576) announced that its Board resolved on 18 May 2026 to introduce an H-Share Award Scheme (Existing Shares). The initiative...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02576":"太美医疗科技"},"translate_title":"太美医疗建议使用现有股份进行H股奖励计划，评级临时会议批准","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02576":1},"content_text":"Zhejiang Taimei Medical Technology Co., Ltd. (“Taimei Medical”, HKEX: 02576) announced that its Board resolved on 18 May 2026 to introduce an H-Share Award Scheme (Existing Shares).\nThe initiative aims to strengthen the company’s long-term incentive framework by aligning employee interests with those of shareholders and the company’s sustainable development goals. Awards will be satisfied solely with existing H shares; no new shares will be issued.\nRegulatory status:\n•  The plan is classified as a “share scheme involving existing shares” under Chapter 17 of the Hong Kong Listing Rules and falls within Rule 17.12.  \n•  Because it does not involve new share issuance, it is exempt from shareholder approval under the Listing Rules.  \n•  Nonetheless, Taimei Medical’s Articles of Association require shareholder endorsement via special resolutions, so the proposal will be tabled at an upcoming extraordinary general meeting (EGM).\nNext steps:\n•  A circular detailing the H-Share Award Scheme and the EGM notice will be dispatched in due course.  \n•  The company advises shareholders and potential investors to exercise caution when dealing in its securities until the EGM outcome is known.\nBoard composition (as of the announcement date):  \nExecutive Directors – Dr. Zhao Lu (Chairman), Ma Dong, Zhang Hongwei, Lu Yiming, Huang Yufei, Ni Xiaomei  \nIndependent Non-executive Directors – Dr. Jiang Xiao, Dr. Li Zhiguo, Fung Che Wai Anthony","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1169737411","isCrawlerRequest":true}